These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1988 related items for PubMed ID: 25906940
1. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H. J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940 [Abstract] [Full Text] [Related]
2. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM. Cerebrovasc Dis; 2013 Jul; 36(4):273-80. PubMed ID: 24135809 [Abstract] [Full Text] [Related]
3. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A. Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [Abstract] [Full Text] [Related]
4. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A. Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [Abstract] [Full Text] [Related]
5. Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study. Acciarresi M, Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C, Pezzini A, Morotti A, Costa P, Padovani A, Csiba L, Szabó L, Sohn SI, Tassinari T, Abdul-Rahim AH, Michel P, Cordier M, Vanacker P, Remillard S, Alberti A, Venti M, D'Amore C, Scoditti U, Denti L, Orlandi G, Chiti A, Gialdini G, Bovi P, Carletti M, Rigatelli A, Putaala J, Tatlisumak T, Masotti L, Lorenzini G, Tassi R, Guideri F, Martini G, Tsivgoulis G, Vadikolias K, Liantinioti C, Corea F, Del Sette M, Ageno W, De Lodovici ML, Bono G, Baldi A, D'Anna S, Sacco S, Carolei A, Tiseo C, Imberti D, Zabzuni D, Doronin B, Volodina V, Consoli D, Galati F, Pieroni A, Toni D, Monaco S, Baronello MM, Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Mosconi MG, Lees KR. J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1363-1368. PubMed ID: 28236595 [Abstract] [Full Text] [Related]
6. CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation. Wu JT, Wang SL, Chu YJ, Long DY, Dong JZ, Fan XW, Yang HT, Duan HY, Yan LJ, Qian P. J Atheroscler Thromb; 2017 Feb 01; 24(2):176-184. PubMed ID: 27301462 [Abstract] [Full Text] [Related]
7. CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are associated with 3-month functional outcome of stroke in patients with prior coronary artery disease. Hoshino T, Ishizuka K, Shimizu S, Uchiyama S. Circ J; 2014 Feb 01; 78(6):1481-5. PubMed ID: 24694770 [Abstract] [Full Text] [Related]
8. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A. Circ Arrhythm Electrophysiol; 2014 Apr 01; 7(2):281-7. PubMed ID: 24610790 [Abstract] [Full Text] [Related]
9. Comparison of the CHADS2, CHA2DS2-VASc and R2CHADS2 Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy. Yoshizawa R, Komatsu T, Kunugita F, Ozawa M, Ohwada S, Satoh Y, Morino Y, Nakamura M. Intern Med; 2017 Nov 01; 56(21):2827-2836. PubMed ID: 28943575 [Abstract] [Full Text] [Related]
10. The Value of the CHADS2 and CHA2DS2-VASc Score for Predicting the Prognosis in Lacunar Stroke with or without Atrial Fibrillation Patients. Yang HJ, Wang GJ, Shuai W, Shen CJ, Kong B, Huang H. J Stroke Cerebrovasc Dis; 2019 Nov 01; 28(11):104143. PubMed ID: 31477449 [Abstract] [Full Text] [Related]
11. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy. Komatsu T, Sato Y, Ozawa M, Kunugita F, Yoshizawa R, Morino Y, Nakamura M. Int Heart J; 2014 Nov 01; 55(2):119-25. PubMed ID: 24632957 [Abstract] [Full Text] [Related]
12. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score. Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA. Can J Cardiol; 2014 Apr 01; 30(4):405-12. PubMed ID: 24582725 [Abstract] [Full Text] [Related]
13. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation . Maruyama K, Uchiyama S, Shiga T, Iijima M, Ishizuka K, Hoshino T, Kitagawa K. Cerebrovasc Dis Extra; 2017 Apr 01; 7(1):35-43. PubMed ID: 28253498 [Abstract] [Full Text] [Related]
14. Comparison of CHA2DS2-VASc, CHADS2 and HATCH scores for the prediction of new-onset atrial fibrillation in cancer patients: A nationwide cohort study of 760,339 study participants with competing risk analysis. Hu WS, Lin CL. Atherosclerosis; 2017 Nov 01; 266():205-211. PubMed ID: 29049919 [Abstract] [Full Text] [Related]
15. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF. Atherosclerosis; 2014 Dec 01; 237(2):504-13. PubMed ID: 25463082 [Abstract] [Full Text] [Related]
16. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation. Tokunaga K, Yamagami H, Koga M, Todo K, Kimura K, Itabashi R, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Kario K, Yagita Y, Kitazono T, Kinoshita N, Takasugi J, Okata T, Yoshimura S, Sato S, Arihiro S, Toyoda K, SAMURAI Study Investigators. Cerebrovasc Dis; 2018 Dec 01; 45(3-4):170-179. PubMed ID: 29597211 [Abstract] [Full Text] [Related]
17. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Apostolakis S, Lane DA, Buller H, Lip GY. Thromb Haemost; 2013 Nov 01; 110(5):1074-9. PubMed ID: 24048467 [Abstract] [Full Text] [Related]
18. Using CHADS2, R2CHADS2, CHA2DS2-VASc score for mortality prediction in patients with abnormal low and high ankle-brachial index. Chi NY, Su HM, Lee WH, Tsai WC, Chen YC, Lin TC, Lu YH, Lee CS, Lin TH, Lai WT, Sheu SH, Hsu PC. Int J Med Sci; 2021 Nov 01; 18(1):276-283. PubMed ID: 33390796 [Abstract] [Full Text] [Related]
19. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY. J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744 [Abstract] [Full Text] [Related]
20. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ. Heart Rhythm; 2015 Apr 10; 12(4):681-6. PubMed ID: 25546809 [Abstract] [Full Text] [Related] Page: [Next] [New Search]